La maladie de Parkinson au Canada (serveur d'exploration) - Checkpoint (PubMed)

Index « MedMesh.i » - entrée « 3,4-Dihydroxyphenylacetic Acid »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
3',5'-Cyclic-GMP Phosphodiesterases < 3,4-Dihydroxyphenylacetic Acid < 3-Hydroxyacyl CoA Dehydrogenases  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000490 (2015) S T Masoud [Canada] ; L M Vecchio [Canada] ; Y. Bergeron [Canada] ; M M Hossain [États-Unis] ; L T Nguyen [Canada] ; M K Bermejo [Canada] ; B. Kile [États-Unis] ; T D Sotnikova [Russie] ; W B Siesser [États-Unis] ; R R Gainetdinov [Russie] ; R M Wightman [États-Unis] ; M G Caron [États-Unis] ; J R Richardson [États-Unis] ; G W Miller [États-Unis] ; A J Ramsey [Canada] ; M. Cyr [Canada] ; A. Salahpour [Canada]Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits.
000865 (2013) Matthew P. Mount [Canada] ; Yi Zhang ; Mandana Amini ; Steve Callaghan ; Jerzy Kulczycki ; Zixu Mao ; Ruth S. Slack ; Hymie Anisman ; David S. ParkPerturbation of transcription factor Nur77 expression mediated by myocyte enhancer factor 2D (MEF2D) regulates dopaminergic neuron loss in response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
001022 (2007) Anne M. Landau [Canada] ; Edouard Kouassi ; Rosmarie Siegrist-Johnstone ; Julie DesbaratsProteasome inhibitor model of Parkinson's disease in mice is confounded by neurotoxicity of the ethanol vehicle.
001549 (2000) S. Callier [Canada] ; M. Morissette ; M. Grandbois ; T. Di PaoloStereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice.
001827 (1996) W G Tatton [Canada] ; J S Wadia ; W Y Ju ; R M Chalmers-Redman ; N A Tatton(-)-Deprenyl reduces neuronal apoptosis and facilitates neuronal outgrowth by altering protein synthesis without inhibiting monoamine oxidase.
001943 (1993) B. Gomez-Mancilla [Canada] ; R. Boucher ; C. Gagnon ; T. Di Paolo ; R. Markstein ; P J BédardEffect of adding the D1 agonist CY 208-243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors.
001A04 (1992) B. Lach [Canada] ; D. Grimes ; B. Benoit ; A. Minkiewicz-JandaCaudate nucleus pathology in Parkinson's disease: ultrastructural and biochemical findings in biopsy material.
001A35 (1991) F B Jolicoeur [Canada] ; R. Rivest ; A. DrumhellerHypokinesia, rigidity, and tremor induced by hypothalamic 6-OHDA lesions in the rat.
001A52 (1991) F B Jolicoeur [Canada] ; R. Rivest ; S. St-Pierre ; A. DrumhellerAntiparkinson-like effects of neurotensin in 6-hydroxydopamine lesioned rats.
001A92 (1990) C. Rouillard [Canada] ; P J Bédard ; T. Di PaoloEffects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393.
001B00 (1990) C. Harnois [Canada] ; T. Di PaoloDecreased dopamine in the retinas of patients with Parkinson's disease.
001B85 (1988) P. Falardeau [Canada] ; S. Bouchard ; P J Bédard ; R. Boucher ; T. Di PaoloBehavioral and biochemical effect of chronic treatment with D-1 and/or D-2 dopamine agonists in MPTP monkeys.
001B93 (1988) T L Perry [Canada] ; K. Jones ; S. Hansen ; R A Wall2-Phenylpyridine and 3-phenylpyridine, constituents of tea, are unlikely to cause idiopathic Parkinson's disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "3,4-Dihydroxyphenylacetic Acid" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i  \
                -Sk "3,4-Dihydroxyphenylacetic Acid" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    3,4-Dihydroxyphenylacetic Acid
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022